{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:47:49Z","timestamp":1790736469197,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dracopolous and Hankins Uveitis Funds"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajo.2025.05.028","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:30:12Z","timestamp":1748399412000},"page":"365-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Incidence and Prevalence of Scleritis Subtypes and Associated Ocular Complications in the TriNetX Database"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6201-1060","authenticated-orcid":false,"given":"Matthew D.","family":"Spangler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6961-1278","authenticated-orcid":false,"given":"Rayna F.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3885-2739","authenticated-orcid":false,"given":"Nila","family":"Kirupaharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-4756","authenticated-orcid":false,"given":"Karen R.","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-7706","authenticated-orcid":false,"given":"Meghan K.","family":"Berkenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.028_bib0002","first-page":"S2","article-title":"Scleromalacia Perforans\u2013 What We Know and What We Can Do","volume":"009","author":"Kopacz","year":"2013","journal-title":"J Clinic Experiment Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.028_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12886-020-01769-3","article-title":"Health system wide \u201cbig data\u201d analysis of rheumatologic conditions and scleritis","volume":"21","author":"Berkenstock","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.028_bib0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.028_bib0006","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz de la Maza","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.028_bib0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.028_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.028_bib0009","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","article-title":"Scleritis and systemic disease association in a community-based referral practice","volume":"148","author":"Raiji","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.05.028_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10384-019-00674-7","article-title":"Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis)","volume":"63","author":"Yoshida","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.05.028_bib0011","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.60.3.192","article-title":"Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis","volume":"60","author":"McGavin","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100178","article-title":"Characteristics and outcomes of patients with scleritis in the IRIS\u00ae Registry (Intelligent Research in Sight) database","volume":"2","author":"Armbrust","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.028_bib0014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40266-024-01105-0","article-title":"Management of scleritis in older adults","volume":"41","author":"Butler","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ajo.2025.05.028_bib0015","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/09273948.2023.2191712","article-title":"Therapeutic outcomes of non-infectious scleritis treated with tumor necrosis factor-alpha inhibitors","volume":"32","author":"Brown","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.ajo.2025.05.028_bib0016","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/art.41709","article-title":"Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and Immune-mediated inflammatory disease","volume":"73","author":"Braithwaite","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.028_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ceo.13761","article-title":"Epidemiology of episcleritis and scleritis in urban Australia","volume":"48","author":"Thong","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.05.028_bib0018","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","article-title":"Incidence and prevalence of episcleritis and scleritis in Northern California","volume":"32","author":"Honik","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.028_bib0019","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2013.05.026","article-title":"Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study","volume":"156","author":"Homayounfar","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.028_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ajo.2020.04.043","article-title":"Epidemiology and clinical characteristics of episcleritis and scleritis in Olmsted county, Minnesota","volume":"217","author":"Xu","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.05.028_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237995","article-title":"Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ajo.2025.05.028_bib0022","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"issue":"9","key":"10.1016\/j.ajo.2025.05.028_bib0023","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0000000000002795","article-title":"Anterior scleritis manifesting after coronavirus disease 2019: a report of two cases","volume":"40","author":"Feizi","year":"2021","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ajo.2025.05.028_bib0024","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1080\/09273948.2023.2296035","article-title":"Incident ocular inflammation after COVID-19 infection in a US veteran population","volume":"32","author":"Roston","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.028_bib0025","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/09273948.2023.2182324","article-title":"Scleritis and episcleritis following Coronavirus disease (COVID-19) vaccination","volume":"31","author":"Sanjay","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2025.05.028_bib0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2022.02.011","article-title":"COVID-19 vaccination and the eye","volume":"240","author":"Wang","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0027","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/09273948.2022.2042319","article-title":"Posterior scleritis following COVID-19 vaccination: a case report","volume":"31","author":"Younus","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2025.05.028_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2025.03.032","article-title":"Incidence and prevalence of uveitis and associated ocular complications in the United States Trinetx database","volume":"276","author":"Kirupaharan","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0029","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2025.05.028_bib0030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3390\/jcm12051969","article-title":"Systemic disease associations in a cohort of Hispanic patients with scleritis","volume":"12","author":"Arruza","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.028_bib0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/jpm12010105","article-title":"Associations between Sj\u00f6gren Syndrome, sociodemographic factors, comorbid conditions, and scleritis in a Taiwanese population-based study","volume":"12","author":"Jan","year":"2022","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.05.028_bib0032","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/cells13020142","article-title":"Ophthalmological manifestations in inflammatory bowel diseases: keep an eye on it","volume":"13","author":"Migliorisi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ajo.2025.05.028_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/25158414211070879","article-title":"Management of noninfectious scleritis","volume":"14","author":"Abdel-Aty","year":"2022","journal-title":"Ophthalmol Eye Dis"},{"issue":"32","key":"10.1016\/j.ajo.2025.05.028_bib0034","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","article-title":"Ophthalmic manifestations in patients with inflammatory bowel disease: a review","volume":"23","author":"Troncoso","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.028_bib0035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41433-022-02101-7","article-title":"Predictors of glaucoma in patients with uveitis and scleritis","volume":"37","author":"Niederer","year":"2023","journal-title":"Eye"},{"issue":"14","key":"10.1016\/j.ajo.2025.05.028_bib0036","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.3390\/jcm12144825","article-title":"Optical coherence tomography: focus on the pathology of macula in scleritis patients","volume":"12","author":"Smeller","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.05.028_bib0037","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results, and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.028_bib0038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.2007.126425","article-title":"Immunopathology of necrotising scleritis","volume":"92","author":"Usui","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.028_bib0039","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/ICU.0000000000000895","article-title":"Peripheral ulcerative keratitis due to systemic diseases","volume":"33","author":"Sura","year":"2022","journal-title":"Curr Opin Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:20:02Z","timestamp":1754918402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"alternative-id":["S0002939425002624"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.028","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Prevalence of Scleritis Subtypes and Associated Ocular Complications in the TriNetX Database","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}